# Jordan Chemicals Export Opportunities (HS 28-38)

![Yugalinks](https://www.yugalinks.com/trade/yugalinks-logo-v3-dark-mode.webp)

> Yugalinks sector export playbook

Explore Jordan HS 28-38 chemicals export opportunities, product portfolio, buyer markets, growth signals, and diversification opportunities.

## Overview

- Exporter: Jordan (JOR)
- Sector: Chemicals
- HS chapters: HS 28-38
- Latest trade year: 2024
- Sector exports: $295.2M
- Products: 30
- Buyer markets: 29
- Average CAGR: +18.9%
- Global sector size: $592.9B

## Product portfolio

| Product | Global size | Your exports | Opportunity | CAGR | Markets | Share |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| HS 300490 - Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $297.5B | $33.4M | $112.6B | +5.6% | 21 | +0.0% |
| HS 300215 - Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, put up in measured doses or in forms or packings for retail sale | $116.6B | $137.3K | $42.7B | +163.4% | 6 | +0.0% |
| HS 382499 - Chemical products, mixtures and preparations: n.e.c. heading 3824 | $30.3B | $4.8M | $20.9B | +5.5% | 13 | +0.0% |
| HS 293359 - Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, (other than malonylurea (barbituric acid) and its derivatives),and loprazolam, mecloqualone, methaqualone, zipeprol and salts thereof | $11.8B | $1.2K | $11.7B | -13.3% | 2 | +0.0% |
| HS 330210 - Odoriferous substances and mixtures: of a kind used in the food or drink industries | $7.9B | $16.8K | $10.7B | -4.2% | 3 | +0.0% |
| HS 330499 - Cosmetic and toilet preparations: n.e.c. in heading no. 3304, for the care of the skin (excluding medicaments, including sunscreen or sun tan preparations) | $18.2B | $2.3M | $8.0B | +8.8% | 4 | +0.0% |
| HS 382200 - Reagents: diagnostic or laboratory reagents on a backing and prepared diagnostic or laboratory reagents whether or not on a backing, other than those of heading no. 3002 or 3006: certified reference material | $17.0B | $275.0K | $7.3B | +4.4% | 4 | +0.0% |
| HS 300439 - Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | $15.1B | $9.4M | $7.2B | +4.3% | 3 | +0.0% |
| HS 293499 - Nucleic acids and their salts, other heterocyclic compounds, n.e.c. in heading number 2934 | $8.1B | $7.5K | $6.7B | +0.0% | 3 | +0.0% |
| HS 310420 - Fertilizers, mineral or chemical: potassic, potassium chloride | $10.1B | $146.6M | $6.2B | +3.8% | 3 | +1.4% |
| HS 300212 - Blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions | $10.9B | $36.9K | $5.6B | +72.3% | 3 | +0.0% |
| HS 293399 - Heterocyclic compounds: n.e.c. in headings no. 2933 | $6.9B | $9.0K | $5.0B | +43.7% | 1 | +0.0% |
| HS 330300 - Perfumes and toilet waters | $8.5B | $81.4K | $5.0B | -3.6% | 3 | +0.0% |
| HS 300220 - Vaccines: for human medicine | $4.6B | $49.3 | $3.4B | -27.6% | 2 | +0.0% |
| HS 382319 - Industrial monocarboxylic fatty acids: acid oils from refining: (other than stearic acid, oleic acid or tall oil fatty acids) | $2.0B | $50.8 | $2.9B | -6.1% | 2 | +0.0% |
| HS 284190 - Salts of oxometallic or peroxometallic acids: n.e.c. in heading no. 2841 | $1.6B | $1.3K | $2.3B | +23.0% | 1 | +0.1% |
| HS 300390 - Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | $3.8B | $2.5M | $2.2B | -0.0% | 2 | +0.1% |
| HS 381800 - Chemical elements: doped for use in electronics, in the form of discs, wafers or similar forms: chemical compounds doped for use in electronics | $3.0B | $740.9 | $2.0B | -1.9% | 1 | +0.0% |
| HS 300420 - Medicaments: containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale | $3.8B | $4.1M | $2.0B | +15.4% | 1 | +0.1% |
| HS 380893 - Herbicides, anti-sprouting products and plant-growth regulators: not containing substances of 3808.50: put up in forms or packings for retail sale or as preparations or articles | $2.0B | $338.9K | $1.7B | +12.4% | 1 | +0.1% |
| HS 293590 - Sulphonamides: n.e.c. in heading no. 2935 | $1.9B | $139.0 | $1.5B | -10.2% | 1 | +0.0% |
| HS 340220 - Washing and cleaning preparations: surface-active, whether or not containing soap (excluding those of heading no. 3401), put up for retail sale | $1.2B | $6.6 | $1.4B | -9.1% | 1 | +0.0% |
| HS 290919 - Ethers: acyclic, and their halogenated, sulphonated, nitrated or nitrosated derivatives, other than diethyl ether | $2.0B | $1.2 | $1.3B | -58.3% | 1 | +0.0% |
| HS 293722 - Steroidal hormones, their derivatives and structural analogues: halogenated derivatives of corticosteroidal hormones | $1.5B | $9.6K | $1.3B | +24.2% | 1 | +0.0% |
| HS 310530 - Fertilizers, mineral or chemical: diammonium hydrogenorthophosphate (diammonium phosphate) | $2.7B | $89.3M | $1.2B | +2.6% | 1 | +3.3% |
| HS 321590 - Ink: writing, drawing and other inks, n.e.c. in heading no. 3215, whether or not concentrated or solid | $674.3M | $1.5M | $1.1B | +27.3% | 1 | +0.2% |
| HS 370790 - Photographic goods: chemical preparations other than sensitised emulsions, put up in measured portions or put up for retail sale in a form ready for use | $979.7M | $47.9K | $1.0B | +9.9% | 1 | +0.0% |
| HS 294190 - Antibiotics: n.e.c. in heading no. 2941 | $883.6M | $213.4K | $989.7M | +17.3% | 1 | +0.0% |
| HS 281820 - Aluminium oxide: other than artificial corundum | $842.4M | $1.9 | $965.3M | -6.6% | 1 | +0.0% |
| HS 293134 - Organo-inorganic compounds: organo-phosphorus derivatives, sodium-3-(hydroxysilyl)propyl methylphosphonate | $590.5M | $23.3 | $959.0M | +246.3% | 1 | +0.0% |

## Best markets

- USA, Puerto Rico and US Virgin Islands (USA): $83.9B calculated opportunity across 15 products.
- Switzerland, Liechtenstein (CHE): $30.7B calculated opportunity across 2 products.
- Germany (DEU): $29.9B calculated opportunity across 11 products.
- China (CHN): $16.8B calculated opportunity across 6 products.
- Netherlands (NLD): $11.5B calculated opportunity across 3 products.
- United Kingdom (GBR): $10.7B calculated opportunity across 5 products.
- Italy (ITA): $9.8B calculated opportunity across 2 products.
- Spain (ESP): $9.8B calculated opportunity across 5 products.
- Slovenia (SVN): $9.7B calculated opportunity across 1 products.
- Belgium (BEL): $7.9B calculated opportunity across 2 products.
- Canada (CAN): $7.5B calculated opportunity across 4 products.
- France (FRA): $7.4B calculated opportunity across 4 products.

## Growth stars

- HS 293134: +246.3% average CAGR, $959.0M calculated opportunity.
- HS 300215: +163.4% average CAGR, $42.7B calculated opportunity.
- HS 300212: +72.3% average CAGR, $5.6B calculated opportunity.
- HS 293399: +43.7% average CAGR, $5.0B calculated opportunity.
- HS 321590: +27.3% average CAGR, $1.1B calculated opportunity.
- HS 293722: +24.2% average CAGR, $1.3B calculated opportunity.
- HS 284190: +23.0% average CAGR, $2.3B calculated opportunity.
- HS 294190: +17.3% average CAGR, $989.7M calculated opportunity.
- HS 300420: +15.4% average CAGR, $2.0B calculated opportunity.
- HS 380893: +12.4% average CAGR, $1.7B calculated opportunity.

## Diversification opportunities

- HS 300490: 21 buyer markets, $112.6B calculated opportunity.
- HS 382499: 13 buyer markets, $20.9B calculated opportunity.
- HS 300215: 6 buyer markets, $42.7B calculated opportunity.
- HS 330499: 4 buyer markets, $8.0B calculated opportunity.
- HS 382200: 4 buyer markets, $7.3B calculated opportunity.
- HS 330210: 3 buyer markets, $10.7B calculated opportunity.
- HS 300439: 3 buyer markets, $7.2B calculated opportunity.
- HS 293499: 3 buyer markets, $6.7B calculated opportunity.
- HS 310420: 3 buyer markets, $6.2B calculated opportunity.
- HS 300212: 3 buyer markets, $5.6B calculated opportunity.

## Method

Reported trade observations and calculated indicators are shown separately. Validate buyers, standards, logistics, pricing, and competition before acting. [Read the Yugalinks methodology](https://www.yugalinks.com/methodology).

## Data sources

- Primary trade series: OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-30). [OECD Data Explorer](https://data-explorer.oecd.org/) - [OECD Terms & Conditions](https://www.oecd.org/termsandconditions/)
- CEPII BACI bilateral trade flows (202601): [dataset page](https://www.cepii.fr/CEPII/en/bdd_modele/bdd_modele_item.asp?id=37) - [BACI documentation](https://www.cepii.fr/DATA_DOWNLOAD/baci/doc/baci_webpage.html) - [Etalab 2.0 Open Licence](https://www.etalab.gouv.fr/wp-content/uploads/2018/11/open-licence.pdf)

This page presents derived Yugalinks views of reported observations and calculated indicators.